nodes	percent_of_prediction	percent_of_DWPC	metapath
Atracurium—Connective tissue disorder—Fluocinolone Acetonide—psoriasis	0.00504	0.00504	CcSEcCtD
Atracurium—Erythema—Calcitriol—psoriasis	0.00503	0.00503	CcSEcCtD
Atracurium—Rash—Tazarotene—psoriasis	0.00482	0.00482	CcSEcCtD
Atracurium—Dermatitis—Tazarotene—psoriasis	0.00481	0.00481	CcSEcCtD
Atracurium—Flushing—Acitretin—psoriasis	0.00477	0.00477	CcSEcCtD
Atracurium—Hypersensitivity—Clobetasol propionate—psoriasis	0.00477	0.00477	CcSEcCtD
Atracurium—Hypoxia—Methotrexate—psoriasis	0.00474	0.00474	CcSEcCtD
Atracurium—Urticaria—Beclomethasone—psoriasis	0.00468	0.00468	CcSEcCtD
Atracurium—Angiopathy—Acitretin—psoriasis	0.00467	0.00467	CcSEcCtD
Atracurium—Cardiac arrest—Mycophenolic acid—psoriasis	0.00465	0.00465	CcSEcCtD
Atracurium—Immune system disorder—Acitretin—psoriasis	0.00465	0.00465	CcSEcCtD
Atracurium—Mediastinal disorder—Fluocinolone Acetonide—psoriasis	0.00462	0.00462	CcSEcCtD
Atracurium—Pruritus—Clobetasol propionate—psoriasis	0.00458	0.00458	CcSEcCtD
Atracurium—Erythema—Acitretin—psoriasis	0.00448	0.00448	CcSEcCtD
Atracurium—Skin disorder—Methoxsalen—psoriasis	0.00448	0.00448	CcSEcCtD
Atracurium—Erythema—Fluocinolone Acetonide—psoriasis	0.00447	0.00447	CcSEcCtD
Atracurium—Wheezing—Triamcinolone—psoriasis	0.00443	0.00443	CcSEcCtD
Atracurium—Convulsion—Calcitriol—psoriasis	0.00436	0.00436	CcSEcCtD
Atracurium—Hypertension—Calcitriol—psoriasis	0.00435	0.00435	CcSEcCtD
Atracurium—Muscular weakness—Mycophenolic acid—psoriasis	0.00431	0.00431	CcSEcCtD
Atracurium—Hypotension—Methoxsalen—psoriasis	0.00431	0.00431	CcSEcCtD
Atracurium—Injury—Cyclosporine—psoriasis	0.0043	0.0043	CcSEcCtD
Atracurium—Hypersensitivity—Fluocinonide—psoriasis	0.0043	0.0043	CcSEcCtD
Atracurium—Injury—Mycophenolate mofetil—psoriasis	0.0042	0.0042	CcSEcCtD
Atracurium—Pruritus—Fluocinonide—psoriasis	0.00413	0.00413	CcSEcCtD
Atracurium—Anaphylactic shock—Calcitriol—psoriasis	0.00411	0.00411	CcSEcCtD
Atracurium—Angioedema—Acitretin—psoriasis	0.00409	0.00409	CcSEcCtD
Atracurium—Anaphylactoid reaction—Cyclosporine—psoriasis	0.00409	0.00409	CcSEcCtD
Atracurium—Rash—Clobetasol propionate—psoriasis	0.00408	0.00408	CcSEcCtD
Atracurium—Dermatitis—Clobetasol propionate—psoriasis	0.00408	0.00408	CcSEcCtD
Atracurium—Skin disorder—Calcitriol—psoriasis	0.00399	0.00399	CcSEcCtD
Atracurium—Injury—Prednisolone—psoriasis	0.00392	0.00392	CcSEcCtD
Atracurium—Injury—Hydrocortisone—psoriasis	0.00383	0.00383	CcSEcCtD
Atracurium—Anaphylactoid reaction—Prednisolone—psoriasis	0.00372	0.00372	CcSEcCtD
Atracurium—Rash—Beclomethasone—psoriasis	0.00372	0.00372	CcSEcCtD
Atracurium—Dermatitis—Beclomethasone—psoriasis	0.00371	0.00371	CcSEcCtD
Atracurium—Rash—Fluocinonide—psoriasis	0.00368	0.00368	CcSEcCtD
Atracurium—Dermatitis—Fluocinonide—psoriasis	0.00368	0.00368	CcSEcCtD
Atracurium—Cardiac arrest—Mycophenolate mofetil—psoriasis	0.00367	0.00367	CcSEcCtD
Atracurium—Angiopathy—Hydroxyurea—psoriasis	0.00366	0.00366	CcSEcCtD
Atracurium—Urticaria—Methoxsalen—psoriasis	0.00366	0.00366	CcSEcCtD
Atracurium—Anaphylactoid reaction—Hydrocortisone—psoriasis	0.00363	0.00363	CcSEcCtD
Atracurium—Injury—Triamcinolone—psoriasis	0.0036	0.0036	CcSEcCtD
Atracurium—Nervous system disorder—Fluocinolone Acetonide—psoriasis	0.00357	0.00357	CcSEcCtD
Atracurium—Skin disorder—Acitretin—psoriasis	0.00355	0.00355	CcSEcCtD
Atracurium—Erythema—Hydroxyurea—psoriasis	0.00352	0.00352	CcSEcCtD
Atracurium—Muscular weakness—Cyclosporine—psoriasis	0.00349	0.00349	CcSEcCtD
Atracurium—Bradycardia—Mycophenolic acid—psoriasis	0.00344	0.00344	CcSEcCtD
Atracurium—Cardiac arrest—Prednisolone—psoriasis	0.00342	0.00342	CcSEcCtD
Atracurium—Anaphylactoid reaction—Triamcinolone—psoriasis	0.00342	0.00342	CcSEcCtD
Atracurium—Muscular weakness—Mycophenolate mofetil—psoriasis	0.0034	0.0034	CcSEcCtD
Atracurium—Hypersensitivity—Methoxsalen—psoriasis	0.0034	0.0034	CcSEcCtD
Atracurium—Bronchospasm—Cyclosporine—psoriasis	0.00336	0.00336	CcSEcCtD
Atracurium—Cardiac arrest—Hydrocortisone—psoriasis	0.00334	0.00334	CcSEcCtD
Atracurium—Connective tissue disorder—Mycophenolic acid—psoriasis	0.00332	0.00332	CcSEcCtD
Atracurium—Injury—Dexamethasone—psoriasis	0.00327	0.00327	CcSEcCtD
Atracurium—Injury—Betamethasone—psoriasis	0.00327	0.00327	CcSEcCtD
Atracurium—Urticaria—Calcitriol—psoriasis	0.00326	0.00326	CcSEcCtD
Atracurium—Pruritus—Methoxsalen—psoriasis	0.00326	0.00326	CcSEcCtD
Atracurium—Muscular weakness—Prednisolone—psoriasis	0.00318	0.00318	CcSEcCtD
Atracurium—Cardiac arrest—Triamcinolone—psoriasis	0.00315	0.00315	CcSEcCtD
Atracurium—Anaphylactoid reaction—Dexamethasone—psoriasis	0.0031	0.0031	CcSEcCtD
Atracurium—Anaphylactoid reaction—Betamethasone—psoriasis	0.0031	0.0031	CcSEcCtD
Atracurium—Muscular weakness—Hydrocortisone—psoriasis	0.0031	0.0031	CcSEcCtD
Atracurium—Angiopathy—Mycophenolic acid—psoriasis	0.00307	0.00307	CcSEcCtD
Atracurium—Mediastinal disorder—Mycophenolic acid—psoriasis	0.00305	0.00305	CcSEcCtD
Atracurium—Convulsion—Hydroxyurea—psoriasis	0.00305	0.00305	CcSEcCtD
Atracurium—Hypersensitivity—Calcitriol—psoriasis	0.00303	0.00303	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.00297	0.00297	CcSEcCtD
Atracurium—Muscular weakness—Triamcinolone—psoriasis	0.00292	0.00292	CcSEcCtD
Atracurium—Pruritus—Calcitriol—psoriasis	0.00291	0.00291	CcSEcCtD
Atracurium—Rash—Methoxsalen—psoriasis	0.00291	0.00291	CcSEcCtD
Atracurium—Dermatitis—Methoxsalen—psoriasis	0.0029	0.0029	CcSEcCtD
Atracurium—Urticaria—Acitretin—psoriasis	0.0029	0.0029	CcSEcCtD
Atracurium—Cardiac arrest—Betamethasone—psoriasis	0.00286	0.00286	CcSEcCtD
Atracurium—Cardiac arrest—Dexamethasone—psoriasis	0.00286	0.00286	CcSEcCtD
Atracurium—Injury—Prednisone—psoriasis	0.00285	0.00285	CcSEcCtD
Atracurium—Nervous system disorder—Hydroxyurea—psoriasis	0.00281	0.00281	CcSEcCtD
Atracurium—Skin disorder—Hydroxyurea—psoriasis	0.00279	0.00279	CcSEcCtD
Atracurium—Bradycardia—Mycophenolate mofetil—psoriasis	0.00272	0.00272	CcSEcCtD
Atracurium—Hypersensitivity—Acitretin—psoriasis	0.00269	0.00269	CcSEcCtD
Atracurium—Connective tissue disorder—Cyclosporine—psoriasis	0.00269	0.00269	CcSEcCtD
Atracurium—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.00269	0.00269	CcSEcCtD
Atracurium—Muscular weakness—Betamethasone—psoriasis	0.00265	0.00265	CcSEcCtD
Atracurium—Muscular weakness—Dexamethasone—psoriasis	0.00265	0.00265	CcSEcCtD
Atracurium—Connective tissue disorder—Mycophenolate mofetil—psoriasis	0.00262	0.00262	CcSEcCtD
Atracurium—Rash—Calcitriol—psoriasis	0.00259	0.00259	CcSEcCtD
Atracurium—Dermatitis—Calcitriol—psoriasis	0.00259	0.00259	CcSEcCtD
Atracurium—Pruritus—Acitretin—psoriasis	0.00259	0.00259	CcSEcCtD
Atracurium—Pruritus—Fluocinolone Acetonide—psoriasis	0.00258	0.00258	CcSEcCtD
Atracurium—Dyspnoea—Hydroxyurea—psoriasis	0.00256	0.00256	CcSEcCtD
Atracurium—Convulsion—Mycophenolic acid—psoriasis	0.00255	0.00255	CcSEcCtD
Atracurium—Hypertension—Mycophenolic acid—psoriasis	0.00254	0.00254	CcSEcCtD
Atracurium—Flushing—Cyclosporine—psoriasis	0.00254	0.00254	CcSEcCtD
Atracurium—Bradycardia—Prednisolone—psoriasis	0.00254	0.00254	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.00249	0.00249	CcSEcCtD
Atracurium—Cardiac arrest—Prednisone—psoriasis	0.00249	0.00249	CcSEcCtD
Atracurium—Angiopathy—Cyclosporine—psoriasis	0.00248	0.00248	CcSEcCtD
Atracurium—Bradycardia—Hydrocortisone—psoriasis	0.00248	0.00248	CcSEcCtD
Atracurium—Mediastinal disorder—Cyclosporine—psoriasis	0.00247	0.00247	CcSEcCtD
Atracurium—Angiopathy—Mycophenolate mofetil—psoriasis	0.00242	0.00242	CcSEcCtD
Atracurium—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.00241	0.00241	CcSEcCtD
Atracurium—Connective tissue disorder—Hydrocortisone—psoriasis	0.00239	0.00239	CcSEcCtD
Atracurium—Nervous system disorder—Mycophenolic acid—psoriasis	0.00236	0.00236	CcSEcCtD
Atracurium—Tachycardia—Mycophenolic acid—psoriasis	0.00235	0.00235	CcSEcCtD
Atracurium—Skin disorder—Mycophenolic acid—psoriasis	0.00233	0.00233	CcSEcCtD
Atracurium—Bradycardia—Triamcinolone—psoriasis	0.00233	0.00233	CcSEcCtD
Atracurium—Muscular weakness—Prednisone—psoriasis	0.00231	0.00231	CcSEcCtD
Atracurium—Rash—Acitretin—psoriasis	0.0023	0.0023	CcSEcCtD
Atracurium—Dermatitis—Acitretin—psoriasis	0.0023	0.0023	CcSEcCtD
Atracurium—Rash—Fluocinolone Acetonide—psoriasis	0.0023	0.0023	CcSEcCtD
Atracurium—Dermatitis—Fluocinolone Acetonide—psoriasis	0.0023	0.0023	CcSEcCtD
Atracurium—Anaphylactoid reaction—Methotrexate—psoriasis	0.00226	0.00226	CcSEcCtD
Atracurium—Hypotension—Mycophenolic acid—psoriasis	0.00225	0.00225	CcSEcCtD
Atracurium—Immune system disorder—Hydrocortisone—psoriasis	0.0022	0.0022	CcSEcCtD
Atracurium—Angioedema—Cyclosporine—psoriasis	0.00218	0.00218	CcSEcCtD
Atracurium—Erythema—Prednisolone—psoriasis	0.00217	0.00217	CcSEcCtD
Atracurium—Dyspnoea—Mycophenolic acid—psoriasis	0.00214	0.00214	CcSEcCtD
Atracurium—Angioedema—Mycophenolate mofetil—psoriasis	0.00212	0.00212	CcSEcCtD
Atracurium—Erythema—Hydrocortisone—psoriasis	0.00212	0.00212	CcSEcCtD
Atracurium—Bradycardia—Betamethasone—psoriasis	0.00212	0.00212	CcSEcCtD
Atracurium—Bradycardia—Dexamethasone—psoriasis	0.00212	0.00212	CcSEcCtD
Atracurium—Hypersensitivity—Hydroxyurea—psoriasis	0.00211	0.00211	CcSEcCtD
Atracurium—Convulsion—Cyclosporine—psoriasis	0.00206	0.00206	CcSEcCtD
Atracurium—Hypertension—Cyclosporine—psoriasis	0.00206	0.00206	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.00201	0.00201	CcSEcCtD
Atracurium—Convulsion—Mycophenolate mofetil—psoriasis	0.00201	0.00201	CcSEcCtD
Atracurium—Hypertension—Mycophenolate mofetil—psoriasis	0.00201	0.00201	CcSEcCtD
Atracurium—Erythema—Triamcinolone—psoriasis	0.00199	0.00199	CcSEcCtD
Atracurium—Angioedema—Prednisolone—psoriasis	0.00198	0.00198	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.00197	0.00197	CcSEcCtD
Atracurium—Anaphylactic shock—Cyclosporine—psoriasis	0.00194	0.00194	CcSEcCtD
Atracurium—Angioedema—Hydrocortisone—psoriasis	0.00193	0.00193	CcSEcCtD
Atracurium—Nervous system disorder—Cyclosporine—psoriasis	0.00191	0.00191	CcSEcCtD
Atracurium—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.0019	0.0019	CcSEcCtD
Atracurium—Skin disorder—Cyclosporine—psoriasis	0.00189	0.00189	CcSEcCtD
Atracurium—Angiopathy—Betamethasone—psoriasis	0.00189	0.00189	CcSEcCtD
Atracurium—Angiopathy—Dexamethasone—psoriasis	0.00189	0.00189	CcSEcCtD
Atracurium—Convulsion—Prednisolone—psoriasis	0.00188	0.00188	CcSEcCtD
Atracurium—Hypertension—Prednisolone—psoriasis	0.00187	0.00187	CcSEcCtD
Atracurium—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.00186	0.00186	CcSEcCtD
Atracurium—Tachycardia—Mycophenolate mofetil—psoriasis	0.00185	0.00185	CcSEcCtD
Atracurium—Skin disorder—Mycophenolate mofetil—psoriasis	0.00184	0.00184	CcSEcCtD
Atracurium—Bradycardia—Prednisone—psoriasis	0.00184	0.00184	CcSEcCtD
Atracurium—Convulsion—Hydrocortisone—psoriasis	0.00183	0.00183	CcSEcCtD
Atracurium—Hypertension—Hydrocortisone—psoriasis	0.00183	0.00183	CcSEcCtD
Atracurium—Angioedema—Triamcinolone—psoriasis	0.00182	0.00182	CcSEcCtD
Atracurium—Rash—Hydroxyurea—psoriasis	0.00181	0.00181	CcSEcCtD
Atracurium—Erythema—Dexamethasone—psoriasis	0.00181	0.00181	CcSEcCtD
Atracurium—Erythema—Betamethasone—psoriasis	0.00181	0.00181	CcSEcCtD
Atracurium—Dermatitis—Hydroxyurea—psoriasis	0.00181	0.00181	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.00179	0.00179	CcSEcCtD
Atracurium—Connective tissue disorder—Prednisone—psoriasis	0.00178	0.00178	CcSEcCtD
Atracurium—Hypotension—Mycophenolate mofetil—psoriasis	0.00177	0.00177	CcSEcCtD
Atracurium—Anaphylactic shock—Prednisolone—psoriasis	0.00177	0.00177	CcSEcCtD
Atracurium—Dyspnoea—Cyclosporine—psoriasis	0.00173	0.00173	CcSEcCtD
Atracurium—Anaphylactic shock—Hydrocortisone—psoriasis	0.00173	0.00173	CcSEcCtD
Atracurium—Convulsion—Triamcinolone—psoriasis	0.00173	0.00173	CcSEcCtD
Atracurium—Tachycardia—Prednisolone—psoriasis	0.00173	0.00173	CcSEcCtD
Atracurium—Hypertension—Triamcinolone—psoriasis	0.00172	0.00172	CcSEcCtD
Atracurium—Pruritus—Mycophenolic acid—psoriasis	0.0017	0.0017	CcSEcCtD
Atracurium—Nervous system disorder—Hydrocortisone—psoriasis	0.00169	0.00169	CcSEcCtD
Atracurium—Dyspnoea—Mycophenolate mofetil—psoriasis	0.00169	0.00169	CcSEcCtD
Atracurium—Tachycardia—Hydrocortisone—psoriasis	0.00169	0.00169	CcSEcCtD
Atracurium—Flushing—Prednisone—psoriasis	0.00168	0.00168	CcSEcCtD
Atracurium—Skin disorder—Hydrocortisone—psoriasis	0.00168	0.00168	CcSEcCtD
Atracurium—Angioedema—Betamethasone—psoriasis	0.00165	0.00165	CcSEcCtD
Atracurium—Angioedema—Dexamethasone—psoriasis	0.00165	0.00165	CcSEcCtD
Atracurium—Angiopathy—Prednisone—psoriasis	0.00164	0.00164	CcSEcCtD
Atracurium—Immune system disorder—Prednisone—psoriasis	0.00163	0.00163	CcSEcCtD
Atracurium—Anaphylactic shock—Triamcinolone—psoriasis	0.00163	0.00163	CcSEcCtD
Atracurium—Hypotension—Hydrocortisone—psoriasis	0.00161	0.00161	CcSEcCtD
Atracurium—Tachycardia—Triamcinolone—psoriasis	0.00159	0.00159	CcSEcCtD
Atracurium—Erythema—Prednisone—psoriasis	0.00158	0.00158	CcSEcCtD
Atracurium—Convulsion—Dexamethasone—psoriasis	0.00157	0.00157	CcSEcCtD
Atracurium—Convulsion—Betamethasone—psoriasis	0.00157	0.00157	CcSEcCtD
Atracurium—Hypertension—Betamethasone—psoriasis	0.00156	0.00156	CcSEcCtD
Atracurium—Hypertension—Dexamethasone—psoriasis	0.00156	0.00156	CcSEcCtD
Atracurium—Urticaria—Cyclosporine—psoriasis	0.00154	0.00154	CcSEcCtD
Atracurium—Rash—Mycophenolic acid—psoriasis	0.00152	0.00152	CcSEcCtD
Atracurium—Dermatitis—Mycophenolic acid—psoriasis	0.00151	0.00151	CcSEcCtD
Atracurium—Urticaria—Mycophenolate mofetil—psoriasis	0.00151	0.00151	CcSEcCtD
Atracurium—Anaphylactic shock—Betamethasone—psoriasis	0.00148	0.00148	CcSEcCtD
Atracurium—Anaphylactic shock—Dexamethasone—psoriasis	0.00148	0.00148	CcSEcCtD
Atracurium—Dyspnoea—Triamcinolone—psoriasis	0.00145	0.00145	CcSEcCtD
Atracurium—Nervous system disorder—Betamethasone—psoriasis	0.00145	0.00145	CcSEcCtD
Atracurium—Nervous system disorder—Dexamethasone—psoriasis	0.00145	0.00145	CcSEcCtD
Atracurium—Tachycardia—Dexamethasone—psoriasis	0.00144	0.00144	CcSEcCtD
Atracurium—Tachycardia—Betamethasone—psoriasis	0.00144	0.00144	CcSEcCtD
Atracurium—Angioedema—Prednisone—psoriasis	0.00144	0.00144	CcSEcCtD
Atracurium—Hypersensitivity—Cyclosporine—psoriasis	0.00143	0.00143	CcSEcCtD
Atracurium—Urticaria—Prednisolone—psoriasis	0.00141	0.00141	CcSEcCtD
Atracurium—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.0014	0.0014	CcSEcCtD
Atracurium—Hypotension—Dexamethasone—psoriasis	0.00138	0.00138	CcSEcCtD
Atracurium—Hypotension—Betamethasone—psoriasis	0.00138	0.00138	CcSEcCtD
Atracurium—Pruritus—Cyclosporine—psoriasis	0.00138	0.00138	CcSEcCtD
Atracurium—Urticaria—Hydrocortisone—psoriasis	0.00137	0.00137	CcSEcCtD
Atracurium—Angiopathy—Methotrexate—psoriasis	0.00137	0.00137	CcSEcCtD
Atracurium—Immune system disorder—Methotrexate—psoriasis	0.00137	0.00137	CcSEcCtD
Atracurium—Convulsion—Prednisone—psoriasis	0.00136	0.00136	CcSEcCtD
Atracurium—Mediastinal disorder—Methotrexate—psoriasis	0.00136	0.00136	CcSEcCtD
Atracurium—Hypertension—Prednisone—psoriasis	0.00136	0.00136	CcSEcCtD
Atracurium—Pruritus—Mycophenolate mofetil—psoriasis	0.00134	0.00134	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.00133	0.00133	CcSEcCtD
Atracurium—Erythema—Methotrexate—psoriasis	0.00132	0.00132	CcSEcCtD
Atracurium—Hypersensitivity—Prednisolone—psoriasis	0.0013	0.0013	CcSEcCtD
Atracurium—Urticaria—Triamcinolone—psoriasis	0.00129	0.00129	CcSEcCtD
Atracurium—Anaphylactic shock—Prednisone—psoriasis	0.00129	0.00129	CcSEcCtD
Atracurium—Hypersensitivity—Hydrocortisone—psoriasis	0.00127	0.00127	CcSEcCtD
Atracurium—Nervous system disorder—Prednisone—psoriasis	0.00126	0.00126	CcSEcCtD
Atracurium—Tachycardia—Prednisone—psoriasis	0.00125	0.00125	CcSEcCtD
Atracurium—Skin disorder—Prednisone—psoriasis	0.00125	0.00125	CcSEcCtD
Atracurium—Rash—Cyclosporine—psoriasis	0.00123	0.00123	CcSEcCtD
Atracurium—Dermatitis—Cyclosporine—psoriasis	0.00122	0.00122	CcSEcCtD
Atracurium—Pruritus—Hydrocortisone—psoriasis	0.00122	0.00122	CcSEcCtD
Atracurium—Hypersensitivity—Triamcinolone—psoriasis	0.0012	0.0012	CcSEcCtD
Atracurium—Rash—Mycophenolate mofetil—psoriasis	0.0012	0.0012	CcSEcCtD
Atracurium—Dermatitis—Mycophenolate mofetil—psoriasis	0.00119	0.00119	CcSEcCtD
Atracurium—Urticaria—Dexamethasone—psoriasis	0.00117	0.00117	CcSEcCtD
Atracurium—Urticaria—Betamethasone—psoriasis	0.00117	0.00117	CcSEcCtD
Atracurium—Pruritus—Triamcinolone—psoriasis	0.00115	0.00115	CcSEcCtD
Atracurium—Convulsion—Methotrexate—psoriasis	0.00114	0.00114	CcSEcCtD
Atracurium—Rash—Prednisolone—psoriasis	0.00112	0.00112	CcSEcCtD
Atracurium—Dermatitis—Prednisolone—psoriasis	0.00111	0.00111	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.00111	0.00111	CcSEcCtD
Atracurium—Rash—Hydrocortisone—psoriasis	0.00109	0.00109	CcSEcCtD
Atracurium—Dermatitis—Hydrocortisone—psoriasis	0.00109	0.00109	CcSEcCtD
Atracurium—Anaphylactic shock—Methotrexate—psoriasis	0.00107	0.00107	CcSEcCtD
Atracurium—Nervous system disorder—Methotrexate—psoriasis	0.00105	0.00105	CcSEcCtD
Atracurium—Pruritus—Dexamethasone—psoriasis	0.00104	0.00104	CcSEcCtD
Atracurium—Pruritus—Betamethasone—psoriasis	0.00104	0.00104	CcSEcCtD
Atracurium—Skin disorder—Methotrexate—psoriasis	0.00104	0.00104	CcSEcCtD
Atracurium—Rash—Triamcinolone—psoriasis	0.00103	0.00103	CcSEcCtD
Atracurium—Dermatitis—Triamcinolone—psoriasis	0.00102	0.00102	CcSEcCtD
Atracurium—Urticaria—Prednisone—psoriasis	0.00102	0.00102	CcSEcCtD
Atracurium—Hypotension—Methotrexate—psoriasis	0.001	0.001	CcSEcCtD
Atracurium—Dyspnoea—Methotrexate—psoriasis	0.000958	0.000958	CcSEcCtD
Atracurium—Hypersensitivity—Prednisone—psoriasis	0.000947	0.000947	CcSEcCtD
Atracurium—Rash—Betamethasone—psoriasis	0.000931	0.000931	CcSEcCtD
Atracurium—Rash—Dexamethasone—psoriasis	0.000931	0.000931	CcSEcCtD
Atracurium—Dermatitis—Dexamethasone—psoriasis	0.00093	0.00093	CcSEcCtD
Atracurium—Dermatitis—Betamethasone—psoriasis	0.00093	0.00093	CcSEcCtD
Atracurium—Pruritus—Prednisone—psoriasis	0.00091	0.00091	CcSEcCtD
Atracurium—Urticaria—Methotrexate—psoriasis	0.000854	0.000854	CcSEcCtD
Atracurium—Rash—Prednisone—psoriasis	0.000811	0.000811	CcSEcCtD
Atracurium—Dermatitis—Prednisone—psoriasis	0.00081	0.00081	CcSEcCtD
Atracurium—Hypersensitivity—Methotrexate—psoriasis	0.000792	0.000792	CcSEcCtD
Atracurium—Pruritus—Methotrexate—psoriasis	0.00076	0.00076	CcSEcCtD
Atracurium—Rash—Methotrexate—psoriasis	0.000678	0.000678	CcSEcCtD
Atracurium—Dermatitis—Methotrexate—psoriasis	0.000677	0.000677	CcSEcCtD
